ALS News Today

June 17, 2022June 17, 2022

B12 Slows Functional Decline in Early-stage ALS, Data Show

ALS News Today

Treatment with ultrahigh-dose methylcobalamin — the physiologically active form of vitamin B12 — effectively slowed functional decline in people with early-stage amyotrophic lateral sclerosis (ALS) and moderate progression, data from ... Read more

June 16, 2022June 16, 2022

Disqualified Ironman Competitor Lends a Hand, Finishes a Hero

ALS News Today, COVID-19 News

Patrick Harfield was on his last legs. Between the elevation gain, the heat, and the cold from the swim in the Sand Hollow Reservoir, the 44-year-old experienced triathlete, competing in ... Read more

June 15, 2022June 15, 2022

ALS Association Greater Chicago Chapter Goes to Bat Against Disease

ALS News Today

The Greater Chicago Chapter of the ALS Association is in high gear to end amyotrophic lateral sclerosis (ALS), with multiple awareness and fundraising events taking place throughout June and July. ... Read more

June 14, 2022June 14, 2022

Radicava ORS Shows Safety, Tolerability Over Nearly Year of Use

ALS News Today

Radicava ORS, an oral formulation of edaravone recently approved to treat amyotrophic lateral sclerosis (ALS) in the U.S., was safe and generally well-tolerated over almost a year of treatment in ... Read more

June 13, 2022June 13, 2022

Albrioza, Oral ALS Therapy Known as AMX0035, Approved in Canada

ALS News Today

Albrioza, formerly called AMX0035, has been given conditional approval by Health Canada for the treatment of amyotrophic lateral sclerosis (ALS). The decision marks a first approval for Albrioza by a ... Read more

June 10, 2022June 10, 2022

NU-9 Is Now AKV9, and Doing Well in Preclinical Studies

ALS News Today

AKAVA Therapeutics’ experimental therapy AKV9, formerly NU-9, was superior to approved therapies for amyotrophic lateral sclerosis (ALS) at improving the health of lab-grown upper motor neurons from a mouse model of the ... Read more

June 9, 2022June 9, 2022

CNM-Au8 Extends Survival, RESCUE-ALS Study Suggests

ALS News Today

Treatment with the experimental gold nanocrystal therapy CNM-Au8 decreased the risk of mortality by 64% among people with early amyotrophic lateral sclerosis (ALS), compared to what would be expected without ... Read more

June 8, 2022June 8, 2022

Starting Tofersen Early Slows ALS Progression Better: Trial Data

ALS News Today

Early use of Biogen’s tofersen significantly slows disability progression, as well as a decline in lung function, muscle strength, and quality of life in amyotrophic lateral sclerosis (ALS) patients with mutations in ... Read more

June 7, 2022June 7, 2022

Dutch Bros Coffee Raises $2.3M for MDA in One Day

ALS News Today

Dutch Bros Coffee has long supported efforts from the Muscular Dystrophy Association (MDA) to help patients with amyotrophic lateral sclerosis (ALS) and other neuromuscular diseases and to fund research. It ... Read more

June 6, 2022June 6, 2022

FDA Pushes Decision on AMX0035 to September for Further Review

ALS News Today

The U.S. Food and Drug Administration (FDA) is extending by three months its review of AMX0035, Amylyx Pharmaceuticals’ experimental oral therapy for amyotrophic lateral sclerosis (ALS). A decision — originally ... Read more

June 3, 2022June 3, 2022

Performer With ALS Returns to Acting for ‘Reel’-life Diagnosis

ALS News Today

Lisa Cross thought having amyotrophic lateral sclerosis (ALS) meant she would have to give up on acting and the theater. A longtime stage actor, Cross, 66, had worked in just ... Read more

June 2, 2022June 2, 2022

Eledon’s Antibody, Tegoprubart, Shows Promise in ALS Phase 2 Trial

ALS News Today

Eledon Pharmaceuticals’ investigational antibody-based therapy, tegoprubart, safely and effectively reduces levels of inflammatory biomarkers in adults with amyotrophic lateral sclerosis (ALS), according to top-line data from a Phase 2a clinical ... Read more

June 1, 2022June 1, 2022

MDA Joins Major League Baseball to Mark ‘Lou Gehrig Day’ Across June

ALS News Today

Major league baseball teams are poised to mark Lou Gehrig Day, set aside to honor the legendary New York Yankees first baseman whose career was cut short amyotrophic lateral sclerosis (ALS), ... Read more

May 31, 2022May 31, 2022

Masitinib Being Reviewed for OK in Canada as Add-on ALS Therapy

ALS News Today

Health Canada has started to review AB Science’s application requesting that masitinib be approved as an add-on therapy for amyotrophic lateral sclerosis (ALS). The application will be reviewed under the notice ... Read more

May 27, 2022May 27, 2022

World-renowned ALS Researcher, Clinician to Receive MDA Award

ALS News Today

Stanley H. Appel, a world-renowned expert in amyotrophic lateral sclerosis (ALS) and the founder of the first multidisciplinary clinic dedicated to ALS care and research in the U.S., will receive ... Read more